Skip to main content
Sopharma AD logo

Sopharma AD — Investor Relations & Filings

Ticker · SFA ISIN · BG11SOSOBT18 LEI · 097900BGGW0000048796 BSOBGN Manufacturing
Open in API
Filings indexed 1,479 across all filing types
Latest filing 2026-01-09 Regulatory Filings
Country BG Bulgaria
Listing BSOBGN SFA

About Sopharma AD

https://www.sopharmagroup.com/

Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.

Recent filings

Filing Released Lang Actions
Statement under Art. 32, para. 7 of the Law on the Introduction of the Euro in the Republic of Bulgaria (LIERB) regarding the initial public offering of an issue of warrants with an exercise period...
Regulatory Filings Classification · 95% confidence The document is a formal notification regarding the impact of the euro introduction on a warrant issue. It references a prospectus and directs readers to external websites to view the full details. Since it is a short regulatory notification regarding a specific financial instrument and its regulatory status rather than the prospectus itself or a financial report, it falls under the general regulatory announcement category.
2026-01-09 English
Announcement in accordance with art. 89t of the LPOS regarding the initiation of an initial public offering of an issue of warrants with an exercise period of up to 3 years
Regulatory Filings
2026-01-09 Polish
Notification for sale of treasury shares
Transaction in Own Shares Classification · 100% confidence The document is a short notification regarding the sale of treasury shares by the company. It explicitly mentions the transaction date, the number of shares sold, the total value, and the resulting balance of treasury shares. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers share buybacks or sales of treasury shares.
2026-01-09 English
Supplement No 1 to the exemption document dated 7 November 2025
Regulatory Filings
2026-01-08 Polish
Notification for sale of treasury shares
Transaction in Own Shares Classification · 100% confidence The document is a short notification regarding the sale of treasury shares by 'Sopharma' AD. It specifies the number of shares sold, the percentage of share capital, the transaction value, and the resulting total number of treasury shares held. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers share buybacks or sales of treasury shares.
2026-01-08 English
Notification for sale of treasury shares
Transaction in Own Shares Classification · 100% confidence The document is a short notification regarding the sale of treasury shares by 'Sopharma' AD. It explicitly details the number of shares sold, the transaction date, the price, and the resulting total of treasury shares held. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers share buybacks or sales of treasury shares.
2026-01-06 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.